Followers | 507 |
Posts | 10138 |
Boards Moderated | 0 |
Alias Born | 04/28/2014 |
Sunday, November 29, 2015 1:36:56 PM
bullish 7.54
resistance breakout
uptrending higher highs higher lows
## source: finance.yahoo.com
Wed, 25 Nov 2015 23:28:49 GMT ~ Seneca Foods Corp (SENEA): Are Hedge Funds Right About This Stock?
read full: http://www.insidermonkey.com/blog/seneca-foods-corp-senea-are-hedge-funds-right-about-this-stock-389296/
*********************************************************
Tue, 24 Nov 2015 13:13:38 GMT ~ Compugen to Present at the Oppenheimer Healthcare Conference in New York
[at noodls] - 263e58e9-e35a-4356-879d-b0c60673032c.pdf FOR IMMEDIATE RELEASE Tel Aviv, Israel - November 24, 2015 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Ari ...
read full: http://www.noodls.com/view/7B34337F6D7EA3237CEF57A94685982ED7E6C8C6
*********************************************************
Tue, 24 Nov 2015 12:00:00 GMT ~ Compugen to Present at the Oppenheimer Healthcare Conference in New York
[Business Wire] - Compugen Ltd. , a leading predictive drug discovery company, today announced that Ari Krashin, Chief Financial Officer of Compugen, will present a corporate overview and update at the Oppenheimer 26th Annual Healthcare Conference in New York, on Tuesday, December 8, 2015.
read full: http://finance.yahoo.com/news/compugen-present-oppenheimer-healthcare-conference-120000947.html
*********************************************************
Thu, 12 Nov 2015 13:16:03 GMT ~ Compugen to Present at Jefferies 2015 Global Healthcare Conference in London
[at noodls] - 90f60e8b-731a-4e9b-86f8-2872812c6014.pdf FOR IMMEDIATE RELEASE Tel Aviv, Israel - November 12, 2015 - Compugen Ltd. (NASDAQ: CGEN), a leading predictive drug discovery company, today announced that Dr. ...
read full: http://www.noodls.com/view/6A77E2809F38C15DC5F1A3886329C7713FAA308D
*********************************************************
Thu, 12 Nov 2015 12:00:00 GMT ~ Compugen to Present at Jefferies 2015 Global Healthcare Conference in London
read full: http://uk.finance.yahoo.com/news/compugen-present-jefferies-2015-global-120000514.html
*********************************************************
$CGEN charts
basic chart ## source: stockcharts.com
basic chart ## source: stockscores.com
big daily chart ## source: stockcharts.com
big weekly chart ## source: stockcharts.com
$CGEN company information
## source: otcmarkets.com
Link: http://www.otcmarkets.com/stock/CGEN/company-info
Ticker: $CGEN
OTC Market Place: Not Available
CIK code: 0001119774
Company name: Compugen Ltd.
Company website: http://www.cgen.com
Incorporated In:
$CGEN share structure
## source: otcmarkets.com
Market Value: $378,918,870 a/o Nov 27, 2015
Shares Outstanding: 50,254,492 a/o Dec 31, 2014
Float: Not Available
Authorized Shares: Not Available
Par Value: No Par Value
$CGEN extra dd links
Company name: Compugen Ltd.
Company website: http://www.cgen.com
## STOCK DETAILS ##
After Hours Quote (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/after-hours
Option Chain (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/option-chain
Historical Prices (yahoo.com): http://finance.yahoo.com/q/hp?s=CGEN+Historical+Prices
Company Profile (yahoo.com): http://finance.yahoo.com/q/pr?s=CGEN+Profile
Industry (yahoo.com): http://finance.yahoo.com/q/in?s=CGEN+Industry
## COMPANY NEWS ##
Market Stream (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/stream
Latest news (otcmarkets.com): http://www.otcmarkets.com/stock/CGEN/news - http://finance.yahoo.com/q/h?s=CGEN+Headlines
## STOCK ANALYSIS ##
Analyst Research (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/analyst-research
Guru Analysis (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/guru-analysis
Stock Report (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/stock-report
Competitors (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/competitors
Stock Consultant (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/stock-consultant
Stock Comparison (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/stock-comparison
Investopedia (investopedia.com): http://www.investopedia.com/markets/stocks/CGEN/?wa=0
Research Reports (otcmarkets.com): http://www.otcmarkets.com/stock/CGEN/research
Basic Tech. Analysis (yahoo.com): http://finance.yahoo.com/q/ta?s=CGEN+Basic+Tech.+Analysis
Barchart (barchart.com): http://www.barchart.com/quotes/stocks/CGEN
DTCC (dtcc.com): http://search2.dtcc.com/?q=Compugen+Ltd.&x=10&y=8&sp_p=all&sp_f=ISO-8859-1
Spoke company information (spoke.com): http://www.spoke.com/search?utf8=%E2%9C%93&q=Compugen+Ltd.
Corporation WIKI (corporationwiki.com): http://www.corporationwiki.com/search/results?term=Compugen+Ltd.&x=0&y=0
WHOIS (domaintools.com): http://whois.domaintools.com/http://www.cgen.com
Alexa (alexa.com): http://www.alexa.com/siteinfo/http://www.cgen.com#
Corporate website internet archive (archive.org): http://web.archive.org/web/*/http://www.cgen.com
## FUNDAMENTALS ##
Call Transcripts (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/call-transcripts
Annual Report (companyspotlight.com): http://www.companyspotlight.com/library/companies/keyword/CGEN
Income Statement (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/financials?query=income-statement
Revenue/EPS (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/revenue-eps
SEC Filings (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/sec-filings
Edgar filings (sec.gov): http://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001119774&owner=exclude&count=40
Latest filings (otcmarkets.com): http://www.otcmarkets.com/stock/CGEN/filings
Latest financials (otcmarkets.com): http://www.otcmarkets.com/stock/CGEN/financials
Short Interest (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/short-interest
Dividend History (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/dividend-history
RegSho (regsho.com): http://www.regsho.com/tools/symbol_stats.php?sym=CGEN&search=search
OTC Short Report (otcshortreport.com): http://otcshortreport.com/index.php?index=CGEN
Short Sales (otcmarkets.com): http://www.otcmarkets.com/stock/CGEN/short-sales
Key Statistics (yahoo.com): http://finance.yahoo.com/q/ks?s=CGEN+Key+Statistics
Insider Roster (yahoo.com): http://finance.yahoo.com/q/ir?s=CGEN+Insider+Roster
Income Statement (yahoo.com): http://finance.yahoo.com/q/is?s=CGEN
Balance Sheet (yahoo.com): http://finance.yahoo.com/q/bs?s=CGEN
Cash Flow (yahoo.com): http://finance.yahoo.com/q/cf?s=CGEN+Cash+Flow&annual
## HOLDINGS ##
Major holdings (cnbc.com): http://data.cnbc.com/quotes/CGEN/tab/8.1
Insider transactions (yahoo.com): http://finance.yahoo.com/q/it?s=CGEN+Insider+Transactions
Insider transactions (secform4.com): http://www.secform4.com/insider-trading/CGEN.htm
Insider transactions (insidercrow.com): http://www.insidercow.com/history/company.jsp?company=CGEN
Ownership Summary (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/ownership-summary
Institutional Holdings (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/institutional-holdings
Insiders (SEC Form 4) (nasdaq.com): http://www.nasdaq.com/symbol/CGEN/insider-trades
Insider Disclosure (otcmarkets.com): http://www.otcmarkets.com/stock/CGEN/insider-transactions
## SOCIAL MEDIA AND OTHER VARIOUS SOURCES ##
PST (pennystocktweets.com): http://www.pennystocktweets.com/stocks/profile/CGEN
Market Watch (marketwatch.com): http://www.marketwatch.com/investing/stock/CGEN
Bloomberg (bloomberg.com): http://www.bloomberg.com/quote/CGEN:US
Morningstar (morningstar.com): http://quotes.morningstar.com/stock/s?t=CGEN
Bussinessweek (businessweek.com): http://investing.businessweek.com/research/stocks/snapshot/snapshot_article.asp?ticker=CGEN
$CGEN DD Notes ~ http://www.ddnotesmaker.com/CGEN
Recent CGEN News
- Compugen to Release First Quarter 2024 Results on Monday, May 20, 2024 • PR Newswire (US) • 05/06/2024 11:00:00 AM
- Compugen to Present New Clinical Data Showing COM701 Triple Combination Preliminary Anti-Tumor Activity in Microsatellite Stable Colorectal Cancer with Liver Metastases at ASCO 2024 • PR Newswire (US) • 04/25/2024 11:00:00 AM
- Compugen Publishes Paper in Cancer Immunology Research Demonstrating Therapeutic Potential of COM503 • PR Newswire (US) • 04/10/2024 11:00:00 AM
- Compugen to Participate in Two Upcoming Investor Conferences • PR Newswire (US) • 04/03/2024 11:00:00 AM
- Compugen Selected for two Oral Presentations at the Keystone Symposium on Cancer Immunotherapy • PR Newswire (US) • 03/11/2024 11:00:00 AM
- Compugen to Present Data Reflecting its Diversified Immuno-Oncology Pipeline at AACR 2024 • PR Newswire (US) • 03/06/2024 12:00:00 PM
- Form 20-F - Annual and transition report of foreign private issuers [Sections 13 or 15(d)] • Edgar (US Regulatory) • 03/05/2024 09:06:21 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 03/05/2024 12:00:24 PM
- Compugen Reports Fourth Quarter and Full Year 2023 Results • PR Newswire (US) • 03/05/2024 12:00:00 PM
- U.S. Futures Dip, Crude Oil Fluctuates • IH Market News • 03/05/2024 11:05:54 AM
- Compugen to Present at the Leerink Partners Global Biopharma Conference 2024 • PR Newswire (US) • 02/26/2024 12:00:00 PM
- Compugen to Release Fourth Quarter and Full Year 2023 Results on Tuesday, March 5, 2024 • PR Newswire (US) • 02/20/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 02/15/2024 12:00:08 PM
- Compugen Announces Appointment of Michelle Mahler M.D. as Chief Medical Officer • PR Newswire (US) • 02/15/2024 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 01/08/2024 12:10:06 PM
- Compugen to Receive $10 Million Milestone Payment Following Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer • PR Newswire (US) • 01/08/2024 12:05:00 PM
- Compugen Regains Compliance with Nasdaq Minimum Bid Price Requirement • PR Newswire (US) • 01/08/2024 12:00:00 PM
- Strong Open For Biotech Following Exclusive Agreement Announcement • AllPennyStocks.com • 12/19/2023 02:30:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 12/19/2023 12:12:07 PM
- Compugen will be Eligible to Receive $10 Million Milestone Payment upon Dosing of First Patient in AstraZeneca Phase 3 Rilvegostomig Trial in Biliary Tract Cancer • PR Newswire (US) • 12/19/2023 12:10:00 PM
- Compugen to Host Conference Call to Discuss Exclusive License Agreement with Gilead for COM503, Novel Immuno-Oncology Pre-Clinical Program Harnessing IL-18 Biology • PR Newswire (US) • 12/19/2023 12:05:00 PM
- Gilead and Compugen Announce Exclusive License Agreement for Novel Pre-Clinical Immunotherapy Program • Business Wire • 12/19/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/07/2023 12:00:05 PM
- Compugen Reports Third Quarter 2023 Results • PR Newswire (US) • 11/07/2023 12:00:00 PM
- Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16] • Edgar (US Regulatory) • 11/06/2023 12:00:07 PM
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock is Expected Soon • NNVC • May 2, 2024 10:07 AM
ILUS Files Form 10-K and Provides Shareholder Update • ILUS • May 2, 2024 8:52 AM
Avant Technologies Names New CEO Following Acquisition of Healthcare Technology and Data Integration Firm • AVAI • May 2, 2024 8:00 AM
Bantec Engaged in a Letter of Intent to Acquire a Small New Jersey Based Manufacturing Company • BANT • May 1, 2024 10:00 AM
Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • BLO • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM